DEFENCE: Determination and Evaluation of the Frequency and Effects of myocardial damage iN patients with a SARS-CoV-2 infEction

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.04301E+13

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2024
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    MPM Linschoten
  • Research Location

    N/A
  • Lead Research Institution

    Dutch CardioVascular Alliance
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

It is currently largely unknown to what extent the heart is involved in COVID-19. Goal The aim of this project, funded by ZonMw, is to determine the occurrence and consequences of heart damage in patients who have experienced COVID-19. Research design Within DEFENCE, several large existing cohorts are brought together: from healthy top athletes and patients in the general population who have recovered from the infection at home to seriously ill patients who have been in hospital. Various tests are performed to detect heart damage, including an MRI scan of the heart. Patients will also receive questionnaires to unravel whether certain complaints, such as palpitations and chest pain in the period after COVID-19, are related to heart damage. By linking the data within this project with external data sources, it will be investigated whether patients after COVID-19 have an increased risk of cardiac complications in the short and long term.